(Q35790376)

10 August 2017

1 reference

title

Targeted therapy for brain tumours (English)

1 reference

10 August 2017

2

Henry Brem

1 reference

10 August 2017

Maciej S Lesniak

1

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Nature Reviews Drug Discovery

10 August 2017

published in

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

499-508

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1414

10 August 2017

exact match

0 references

cites work

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

1 reference

Solid stress generated by spheroid growth estimated using a linear poroelasticity model.

21 January 2018

1 reference

High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.

21 January 2018

1 reference

High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours

21 January 2018

1 reference

Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin

21 January 2018

1 reference

Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors

21 January 2018

1 reference

Nanoparticle technology for delivery of drugs across the blood-brain barrier.

21 January 2018

1 reference

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

21 January 2018

1 reference

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

21 January 2018

1 reference

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

21 January 2018

1 reference

Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy

21 January 2018

1 reference

Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.

21 January 2018

1 reference

Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications

21 January 2018

1 reference

21 January 2018

1 reference

Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.

21 January 2018

1 reference

Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.

21 January 2018

1 reference

Bleomycin and brain tumors. A review

21 January 2018

1 reference

A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme.

21 January 2018

1 reference

Intratumoral doxorubicin in patients with malignant brain gliomas.

21 January 2018

1 reference

Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report.

21 January 2018

1 reference

Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors

21 January 2018

1 reference

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

21 January 2018

1 reference

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

21 January 2018

1 reference

Polymers for the sustained release of proteins and other macromolecules

21 January 2018

1 reference

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.

21 January 2018

1 reference

Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres

21 January 2018

1 reference

Biodegradable long-circulating polymeric nanospheres

21 January 2018

1 reference

Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.

21 January 2018

1 reference

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

21 January 2018

1 reference

In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy

21 January 2018

1 reference

Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain

21 January 2018

1 reference

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

21 January 2018

1 reference

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial

21 January 2018

1 reference

Gliadel for pituitary adenomas and craniopharyngiomas

21 January 2018

1 reference

Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

Camptothecin analogs in malignant gliomas: comparative analysis and characterization

21 January 2018

1 reference

Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy

21 January 2018

1 reference

Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model.

21 January 2018

1 reference

The role of minocycline in the treatment of intracranial 9L glioma.

21 January 2018

1 reference

Multi-pulse drug delivery from a resorbable polymeric microchip device.

21 January 2018

1 reference

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

Integrins: a family of cell surface receptors

21 January 2018

1 reference

Integrin signaling and cell growth control

21 January 2018

1 reference

Integrin-mediated signal transduction

21 January 2018

1 reference

Regulation of apoptosis by integrin receptors

21 January 2018

1 reference

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

21 January 2018

1 reference

Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives

21 January 2018

1 reference

Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses

21 January 2018

1 reference

Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo

21 January 2018

1 reference

Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.

21 January 2018

1 reference

Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.

21 January 2018

1 reference

Comparative analysis of paracrine immunotherapy in experimental brain tumors

21 January 2018

1 reference

Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors.

21 January 2018

1 reference

Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma

21 January 2018

1 reference

A controlled-release microchip

21 January 2018

1 reference

Survival and functional status after resection of recurrent glioblastoma multiforme.

21 January 2018

1 reference

Chemotherapy for malignant gliomas

31 March 2020

1 reference

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

31 March 2020

1 reference

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

31 March 2020

1 reference

A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma

31 March 2020

1 reference

Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics

31 March 2020

1 reference

Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity

31 March 2020

1 reference

Controlled delivery systems for proteins using polyanhydride microspheres

31 March 2020

1 reference

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

31 March 2020

1 reference

Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel

31 March 2020

1 reference

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

31 March 2020

1 reference

Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1414

1 reference

10 August 2017

1 reference